Glucose variability in a 26-week randomized comparison of mealtime treatment with rapid-acting insulin versus glp-1 agonist in participants with type 2 diabetes at high cardiovascular risk

Jeffrey L. Probstfield, Irl B. Hirsch, Barry R. Davis, Andrew Ahmann, Richard Bergenstal, Matthew Gilbert, Connie Kingry, Dorrine Khakpour, Dejian Lai, Sarah L. Pressel, Kelley R. Branch, Matthew Riddle, Kevin D. O'Brien

Research output: Contribution to journalArticlepeer-review

87 Scopus citations

Fingerprint

Dive into the research topics of 'Glucose variability in a 26-week randomized comparison of mealtime treatment with rapid-acting insulin versus glp-1 agonist in participants with type 2 diabetes at high cardiovascular risk'. Together they form a unique fingerprint.

Medicine & Life Sciences